\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes ERCThe ERC is looking for three ERC grantees to participate in the next edition of the ‘Science is Wonderful!’ fair which takes place in March 2025. This event is aimed at primary and secondary school students, and gives them the opportunity to interact with leading researchers and innovators through games, group experiments and quizzes.
More information on the Science is wonderful! science fair, the 2024 edition, what is in it for ERC grantees and what is expected from them, the evaluation criteria and the timeline is available in the application form for ERC grantees which is open until 31 October.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
